References
1. Vece TJ, Young LR. 2016. Update on diffuse lung disease in children. Chest. 149(3):836-845.
2. Nogee LM, de Mello DE, Dehner LP, Colten HR. 1993. Brief report: Deficiency of pulmonary surfactant protein b in congenital alveolar proteinosis. N Engl J Med. 328(6):406-410.
3. Nogee LM, Dunbar AE, 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. 2001. A mutation in the surfactant protein c gene associated with familial interstitial lung disease. N Engl J Med. 344(8):573-579.
4. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. 2005. Abca3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med. 172(8):1026-1031.
5. Deterding RR, Pye C, Fan LL, Langston C. 2005. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol. 40(2):157-165.
6. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C et al. 2007. Diffuse lung disease in young children: Application of a novel classification scheme. Am J Respir Crit Care Med. 176(11):1120-1128.
7. Fan LL, Dishop MK, Galambos C, Askin FB, White FV, Langston C, Liptzin DR, Kroehl ME, Deutsch GH, Young LR et al. 2015. Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the child classification scheme. Ann Am Thorac Soc. 12(10):1498-1505.
8. Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG, Dell S, Fan LL, Hamvas A, Hilman BC et al. 2013. An official american thoracic society clinical practice guideline: Classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 188(3):376-394.
9. Popler J, Lesnick B, Dishop MK, Deterding RR. 2012. New coding in the international classification of diseases, ninth revision, for children’s interstitial lung disease. Chest. 142(3):774-780.
10. Icd-10-cm coding for interstitial lung diseases. 2015. In: Plummer AL, editor. Coding & Billing Quarterly: American Thoracic Society.
11. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. 2009. Research electronic data capture (redcap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 42(2):377-381.
12. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J et al. 2019. The redcap consortium: Building an international community of software platform partners. J Biomed Inform. 95:103208.
13. Clement A, Force ERST. 2004. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J. 24(4):686-697.
14. Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N, Emiralioglu N, Snijders D, Goldbeck L et al. 2018. International management platform for children’s interstitial lung disease (child-eu). Thorax. 73(3):231-239.
15. Soares JJ, Deutsch GH, Moore PE, Fazili MF, Austin ED, Brown RF, Sokolow AG, Hilmes MA, Young LR. 2013. Childhood interstitial lung diseases: An 18-year retrospective analysis. Pediatrics. 132(4):684-691.
16. Temple SEL, Ho G, Bennetts B, Boggs K, Vidic N, Mowat D, Christodoulou J, Schultz A, Gayagay T, Roscioli T et al. 2022. The role of exome sequencing in childhood interstitial or diffuse lung disease. Orphanet J Rare Dis. 17(1):350.
17. Saddi V, Beggs S, Bennetts B, Harrison J, Hime N, Kapur N, Lipsett J, Nogee LM, Phu A, Suresh S et al. 2017. Childhood interstitial lung diseases in immunocompetent children in australia and new zealand: A decade’s experience. Orphanet J Rare Dis. 12(1):133.
18. Terwiel M, Borie R, Crestani B, Galvin L, Bonella F, Fabre A, Froidure A, Griese M, Grutters JC, Johannson K et al. 2022. Genetic testing in interstitial lung disease: An international survey. Respirology. 27(9):747-757.
19. Seidl E, Schwerk N, Carlens J, Wetzke M, Cunningham S, Emiralioglu N, Kiper N, Lange J, Krenke K, Ullmann N et al. 2022. Healthcare resource utilisation and medical costs for children with interstitial lung diseases (child) in europe. Thorax. 77(8):781-789.